Restarting biologic agents in rheumatology patients who developed tuberculosis under TNFα-inhibitor treatment

Gül Öngen (Istanbul, Turkey), Yesim Ozguler, Gulen Hatemi, Serdal Ugurlu, Emire Seyahi, Melike Melikoglu, Sermin Borekci, Ersan Atahan, Hurrem Gul Ongen, Vedat Hamuryudan

Source: International Congress 2015 – Latent TB infection and screening
Session: Latent TB infection and screening
Session type: Oral Presentation
Number: 1451
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Gül Öngen (Istanbul, Turkey), Yesim Ozguler, Gulen Hatemi, Serdal Ugurlu, Emire Seyahi, Melike Melikoglu, Sermin Borekci, Ersan Atahan, Hurrem Gul Ongen, Vedat Hamuryudan. Restarting biologic agents in rheumatology patients who developed tuberculosis under TNFα-inhibitor treatment. Eur Respir J 2015; 46: Suppl. 59, 1451

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The effectiveness of pulmonary TB treatment in patients with organic liver diseases, depending on the way of administration of anti-TB drugs
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016


The particularities of new cases of tuberculosis at homeless people
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013


Tuberculosis in patients receiving treatment of TNF-alpha inhibitors
Source: International Congress 2015 – Case series and clinical conundrums in TB
Year: 2015


Experience of using diaskintest in adult patients with tuberculosis and non-tuberculosis respiratory diseases in a regional TB hospital
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013


The feature of BCG complications in children
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013


Statin use and the risk of tuberculosis: Data from 305,142 patients
Source: International Congress 2016 – New insights into aspects of tuberculosis epidemiology
Year: 2016


Range of additional drug resistance of M.tuberculosis in XDR-TB patients
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016


Side effects of chemical preparations in patients with drug-resistant pulmonary tuberculosis
Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders
Year: 2015

Features of pulmonary tuberculosis in migrants
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015

Detection of tuberculosis in children
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013


Chloroquine as a potential adjunctive therapy in tuberculosis
Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches
Year: 2014


Tuberculosis (TB) and depression
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013

Modern social and clinical characteristics of miliary tuberculosis
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014


Impact of drug injection using on TB-AIDS treatment outcomes
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013

Two case reports: The successful management of pulmonary mycobacterium bohemicum
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016

Lymphocytopenia in pulmonary tuberculosis: Does it have a clinical value?
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016


MOTT as a cause of treatment failure in pulmonary tuberculosis
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013


Patients over 35 years experience more side-effects during latent TB treatment: Experience from an urban hospital with a high incidence of Tuberculosis
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015


Rapid monitoring of tuberculosis treatment response: A multi-centre study
Source: International Congress 2016 – Advances in tuberculosis diagnosis and monitoring of treatment
Year: 2016



Reasons for suspicion of prostate tuberculosis
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016